JAZZ News and Press, Jazz Pharmaceuticals plc From 05/04/22

Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist PR Newswire Jazz licenses development and commercialization rights in U.S., Europe and oth...

Jazz Pharmaceuticals to Participate in the BofA Securities 2022 Global Healthcare Conference PR Newswire DUBLIN , May 3, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the BofA Securities ...

The Polaris International Equity Composite returned -5.24%. Now with ‘higher inflation for longer’ rhetoric, commodities have another leg up as in the past they have served as a hedge against inflation. We are considering the risks of a big slowdown in Europe, contin...

The Polaris Global Equity Composite returned -3.83%. We are constantly assessing the portfolio seeking to ensure that our holdings thrive in an inflationary period. We are actively seeking attractively-priced stocks with good upside potential and lesser downside risk. We belie...

Cannabinoids, such as cannabidivarin (CBDV) could be a therapeutic game-changer. In fact, according to InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Eric Hsu, SVP, Pre-Clinical Research and Development for InMed commented; “Cannabinoids hold tremendous therapeutic potential t...

Cannabinoids, such as cannabidivarin (CBDV) may be rare, but may also have exciting potential. In fact, according to InMed Pharmaceuticals Inc. (NASDAQ: INM), “CBDV is one of the most studied rare cannabinoids and has been the subject of research in autism, epilepsy, acne, alopec...

Jazz Pharmaceuticals to Report 2022 First Quarter Financial Results on May 4, 2022 PR Newswire DUBLIN , April 20, 2022 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2022 first quarter financial results on ...

Most cannabis stocks have seen their shares slide so far this year, but Jazz Pharmaceuticals (NASDAQ: JAZZ) , WM Technology (NASDAQ: MAPS) , and Glass House Brands (OTC: GLAS.F) , have all seen double-digit rises in their shares. All three companies are different...

The recent Sunosi acquisition delivers pipeline synergy as well as making Axsome revenue positive. AXS07 is poised to gain FDA approval to better serve patients afflicted by migraines. AXS05's regulatory issues are now seemingly cleared with approval anticipated for either Q3 or Q...

Best Medical Marijuana Stocks In 2022 Are top marijuana stocks on your radar for 2022? In April the cannabis sector continued to experience significant market volatility in the second quarter of the year. Overall, the stock market has been heavily affected by the War in Ukraine and ...